• Ultrasensitive Chip Detects Cancer Faster, Less Invasively than Current Approaches, Study Suggests
  • Researchers Find Compounds that Kill Chemo-resistant Cancer Cells
  • Mirvetuximab Soravtansine Fails to Delay Disease Progression in FRα-positive Ovarian Cancers, Trial Shows
  • FPA150 Trial Begins Dosing Ovarian, Breast, Endometrial Cancer Patients
  • Phase 2 Trial Completes Dosing First OC Patient with Aivita’s Cell Therapy
  • UPMC Trial to Explore Ampligen Combo for Recurrent Ovarian Cancer
  • Artificial Intelligence May Predict Cancer Survival Better Than Current Methods, Study Suggests
  • Olympic Champion Shannon Miller to Help Honor Ovarian Cancer Heroes
  • Breast Cancer Treatments Could Be Used for Rare Ovarian Cancer, Study Suggests
  • Phase 1 Trial Approved to Test PRGN-3005 UltraCAR-T for Advanced Platinum-resistant Ovarian Cancer
  • 1st Patient Dosed in Phase 1/2 Trial of COTI-2 Plus Chemo for Gynecological and Other Solid Cancers
  • Lynparza Plus Weekly Chemotherapy May Help Patients with Advanced Disease, Phase 1/2 Study Finds